Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools
In the past decade, significant progresses have taken place in the field of cancer immunotherapy. Tumor-targeting immunotherapies are being developed for most human cancers, including melanoma, prostate cancer, glioblastoma, sarcoma, lung carcinoma and hepatocellular carcinoma. The FDA has approved...
Format: | eBook |
---|---|
Language: | English |
Published: |
Frontiers Media SA
2014
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | Open Access: DOAB, download the publication Open Access: DOAB: description of the publication |
Similar Items
-
Cancer Immunotherapy and Next-Generation Clinical Immune Assessment
by: Chao eMa, et al.
Published: (2014-09-01) -
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy
by: Els Lebegge, et al.
Published: (2020-07-01) -
Targeting regulatory T cells for immunotherapy in melanoma
by: Lili Huang, et al.
Published: (2021-04-01) -
The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers
by: Virginia Liberini, et al.
Published: (2021-04-01) -
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
by: Tongyan Liu, et al.
Published: (2019-08-01)